The Association of American Cancer Institutes (AACI) welcomes its newest and 100th member—Cold Spring Harbor Laboratory (CSHL) Cancer Center—one of seven National Cancer Institute–designated basic laboratory cancer centers. The CSHL Cancer Center has nine shared resources that facilitate cancer research with state-of-the-art technology and integral services to ensure that researchers have all the necessary tools to make breakthrough discoveries.
David Tuveson, MD, PhD
Directed by David Tuveson, MD, PhD, the CSHL Cancer Center is committed to exploring the fundamental biology of human cancer. Research at the center covers a broad range of cancer types, including breast, prostate, leukemia, brain, pancreatic, sarcoma, lung, and melanoma. Three scientific research programs provide focus in Gene Regulation and Cell Proliferation, Signal Transduction, and Cancer Genetics.
Founded in 1890 and located on Long Island, New York, the private, not-for-profit CSHL includes 54 laboratories, employing more than 1,100 people including 600 scientists, students, and technicians. In addition to cancer, the laboratory focuses on research areas such as neuroscience, plant biology, and quantitative biology. CSHL serves as a major education institute, annually convening 12,000 scientists for meetings and advanced technology courses. As a basic research cancer center, CSHL Cancer Center members collaborate with local Northwell Health, New York’s largest health-care provider, as well as other clinical centers to ensure that cancer discoveries are translated to the clinic.
More on AACI Membership
AACI’s membership comprises academic and freestanding cancer research centers in the United States and Canada. Forming North America’s cancer research infrastructure, AACI cancer centers are recognized for translating promising research findings into new interventions to prevent and treat cancer.
AACI’s other basic science centers include Sanford Burnham Prebys Medical Discovery Institute, the Salk Institute for Biological Studies (both in California), Purdue Cancer Center (Indiana), Jackson Laboratory (Maine and Connecticut), and Wistar Institute (Pennsylvania). ■
